|
Welcome back to What I’m Hearing, and Happy New Year to everyone who survived ’til ’25. Is it too early to suggest Hollywood will be “fixed in ’26”?
As I mentioned Monday, I’m taking a few days off, and unlike my usual vacations, I’m not holed up in some hotel business center or searching for WiFi on a mountaintop. I’m actually off and offline (I wrote this intro last weekend), back on Monday. Meanwhile, it’s a perfect opportunity for box office guru Scott Mendelson to offer his take on both the holiday movie race and the entire year that was. All yours, Scott…
|
|
|
|
An array of disparate success stories—from period horror gambles and animated sequels to an inter-gen biopic—made up for a lackluster summer and illustrated a new post-pandemic, post-strike, post-#Barbenheimer paradigm in this strange new box office world.
|
|
|
|
So, the Christmas weekend box office total—$163 million—wasn’t entirely on par with the pre-pandemic 2019 sum of $197 million. But in a season without a single Star Wars- or Avatar-sized tentpole, the 14 percent drop from the Before Times number may even be rosier than it initially appears. In a year billed as a Great Holding Pattern of sorts, marred by lingering pandemic distortions and post-strike delays—a rebuilding year for the theatrical business and its Survive Until ’25 mantra—this past weekend modeled a formula: It wasn’t about a single, overperforming tentpole, but rather a slew of thrillers, comedies, biopics, musicals, animated films, and horror movies, all performing solidly.
Mufasa: The Lion King, the closest approximation to a blockbuster, out-earned its domestic debut, with $37 million in its second weekend compared to $35 million in its first, and is on track to crack $200 million domestically. This performance aligns with the past four decades of mid- to late December releases—films as huge as Avatar and as tiny as Mouse Hunt have traded smaller opening weekends for much larger opening-to-final multipliers amid the year-end moviegoing blitz.
Disney’s approximately $200 million-budgeted follow-up won’t come anywhere near the $543 million domestic and $1.66 billion global finish of the previous Lion King remake, in 2019, but that was never in the cards. Presuming it flirts with a $600 million worldwide total, Mufasa’s eventual box office will more closely resemble Aquaman and the Lost Kingdom ($433 million, or 62 percent below Aquaman’s $1.15 billion release) than The Marvels and Joker: Folie à Deux, both of which barely earned $200 million despite their predecessors each topping $1 billion globally.
|
|
|
|
A MESSAGE FROM OUR SPONSOR
|
|
For your awards consideration Max Presents: The HBO Original HOUSE OF THE DRAGON. Following
King Aegon II’s coronation and the death of Queen Rhaenyra’s son, House Targaryen is divided in two. In King’s Landing, Aegon II rules from the Iron Throne, supported by Alicent and the Green Council, under the protection of the largest dragon in Westeros. From exile on Dragonstone, Queen Rhaenyra and her Black Council consider their next move. Civil war looms as both sides seek support from the great houses of Westeros, ultimately amassing armies — and dragons. Don’t miss the series Variety
calls “TV’s GREATEST SPECTACLE”. Now streaming on MAX.
|
|
|
|
In the end, Mufasa is a middle-of-the-road tentpole—think Paramount’s $440 million-grossing Gladiator II or Disney’s own $575 million-grossing Little Mermaid remake—that will offer a fine capstone to Bob Iger’s year, which featured $4 billion worldwide just from Inside Out 2, Deadpool & Wolverine, and Moana 2.
Meanwhile, the success of Focus’s non-franchise vampire flick, Nosferatu, is even more illuminating. Robert Eggers’ R-rated remake of F.W. Murnau’s 1922 silent film performed like a mainstream tentpole, with a $40 million Wednesday-Sunday launch, for several reasons: a strong ensemble cast, a marquee filmmaker, an easy elevator pitch, good reviews, and the promise of some holiday escapism. Focus tried something less conventional, and now the industry has another genre of film that can successfully launch during what has always been a robust period for multiple releases.
The intergenerational biopic A Complete Unknown, which just passed $30 million domestically on day eight, following a $23 million Wednesday-Sunday holiday debut, was another exemplar of spreading the wealth. Whether or not it holds firm over the early months of 2025, the James Mangold-directed drama debuted with support from a solid combination of older moviegoers, who treated Bob Dylan as a marquee character, and younger fans, who just wanted to see Timothée Chalamet talk like he swallowed a bee.
The concurrent success of Nosferatu and A Complete Unknown, especially amid the backdrop of a strong Thanksgiving featuring Wicked: Part One, Moana 2, and Gladiator II, demonstrates the renewed opportunity at the box office. Unlike the summer of #Barbenheimer, in 2023, Hollywood didn’t need to bank on an unprecedented pop culture event. And there may be more good news to come. Relative to budget and expectation, there’s room for Mufasa to continue building, and Nosferatu to demolish precedent for a late-December chiller. Babygirl, the Nicole Kidman-starring erotic thriller, also performed well, auspiciously topping $10 million by day six.
|
A Happy End to a Challenging Year
|
|
The overall total for the domestic box office in 2024 came in at around $8.7 billion, down just 3 percent from last year’s Nolan-Robbie-Cruise-adjusted $8.9 billion cume. Not only was the Christmas weekend off only 14 percent from the pre-pandemic era, but the frame amplified a decidedly strong second half for the theatrical industry. After all, the first five months of the year—acutely battered by strike delays and facing an oft-barren slate—were down 23 percent from 2023. But once the movies showed up, from Bad Boys: Ride or Die to Sonic the Hedgehog 3, the period from June through December was up around 9 percent year over year.
Of course, the total was still well below the $11 billion-plus annual hauls that Hollywood grew accustomed to in the late 2010s. But paramount among the reasons for tempered optimism here: The current predicament has as much to do with supply as demand. Following the heights of the superhero era, Hollywood had to construct an entirely new playbook—discovering (or rediscovering) that, for instance, top-tier box office can result from big films aimed at women (and not just stereotypically male-centric genre films with a female lead). The studios behind The Fall Guy and Gladiator II were banking on women showing up to watch Ryan Gosling and Paul Mescal, respectively. And the industry didn’t need men to turn out for Blake Lively in It Ends With Us or Ariana Grande in Wicked: Part One.
Yes, Disney lorded over its competition this past year, but studios offered a veritable cornucopia of counterprogramming, whether by intent or post-strike cupboard-cleaning necessity, or both. Besides the sky-high grosses for Dune: Part Two and Wicked: Part One, we saw good-to-great showings from smaller-scale, less conventional event films, like the aforementioned It Ends With Us and Longlegs, many of which helped fill in the gaps between periodically underwhelming tentpoles. After M. Night Shyamalan’s Trap underperformed in early August and Badlands outright tanked, Blake Lively’s blockbuster melodrama and Maika Monroe and Nicolas Cage’s thriller mitigated the damage. The industry erred by resting October entirely on the shoulders of one killer clown sequel, but Terrifier 3 was nonetheless up to the challenge.
|
|
|
|
To state the obvious: Hollywood cannot survive by hoping every would-be blockbuster performs at maximum potential. Having an Avatar or an Amazing Spider-Man 2 on deck is not enough. Studios and theater, alike, need an It’s Complicated and a Neighbors, too.
|
A Theatrical Industry, If You Can Keep It
|
|
This new year has been pitched as the first time since 2020 that we will see something approximating a pre-Covid slate of feature releases. Offhand, we’ve got a few more Marvel and DC movies, another Jurassic World, follow-ups to Zootopia and Avatar, and sequels to more recent franchise successes like Wicked and M3GAN. There’s also plenty of optimism for less franchise-minded likely breakouts, including the sure-to-be-controversial Michael Jackson biopic (Michael) and Ryan Coogler’s Sinners, starring Michael B. Jordan.
Alongside this return to semi-normalcy, distributors have come to recognize a theatrical release as creating added value for streaming, rather than as a rival channel. With a likely full slate, presuming Amazon somewhat compensates for the lack of a fully functioning 20th Century Studios, the likes of AMC and Cinemark can finally do their thing without one hand tied behind their backs.
Two of last year’s key patterns are instructive. Firstly, films of all shapes and sizes displayed post-debut staying power far above what would have been expected in pre-Covid times. For instance, Longlegs and The Fall Guy earned out more than three times their respective opening weekends. The hope is that, even amid shrinking exclusivity windows, audiences are reacclimating to seeing a movie when they get around to it, and post-debut buzz can help long after opening weekend.
At the same time, several titles earned more domestically than expected while posting only modest receipts overseas. Twisters earned $270 million in North America, but just $375 million worldwide. The family-skewing If made $111 million domestically but only $190 million globally. Of course, global earnings become less crucial if budgets are small and/or domestic grosses are large enough. Wicked: Part One, for instance, cost $145 million and might top $500 million stateside, so its current 67-33 domestic/overseas split isn’t exactly a catastrophe. With China rarely pitching in and more Hollywood I.P.s skewing domestic in terms of interest and nostalgia, budgets should reflect a global earnings split closer to 50-50 than the pre-Covid standard 35-65 moving forward.
The decline in once-dominant genres and studios’ reliance on past-their-prime brands and franchises are still cause for concern. That’s to say nothing of a generation more addicted to YouTube and video games than to traditional longform entertainment—a challenge exacerbated by an industry dedicated more to convincing kids that Indiana Jones is still cool than to offering of-the-moment, youth-skewing franchises like Five Nights at Freddy’s. And then there are the other macroeconomic challenges: The top six grossers of the year comprised 32 percent of the annual theatrical revenue, up from 28 percent last year, continuing a decade-long trend toward consolidation around a handful of all-encompassing event movies. And that’s without even contemplating the unknowns at Paramount and WBD.
Cautious optimism aside, it’s hard to picture the industry rebounding to 2000s and early 2010s levels in terms of ticket sales. Even the reported $2.2 billion-plus in expected—and long overdue—upgrades to the multiplex experience are as much about maximizing revenue per customer as they are about attracting new business.
However, the aspirational Christmas box office should presage a continued and permanent theatrical recovery. The positive grosses and varied slate together approach a platonic ideal of what the movie theater is supposed to represent, both commercially and culturally. Time will tell if it’s the start of a happily ever after or a false-hope finale before a darker, grittier sequel.
|
|
Thanks to Scott. I’ll be back on Monday to officially usher you into 2025.
See you then.
Matt
|
|
|
|
Puck founding partner Matt Belloni takes you inside the business of Hollywood, using exclusive reporting and insight to explain the backstories on everything from Marvel movies to the streaming wars.
|
|
|
|
Lauren Sherman, a former top executive at Business of Fashion, is the preeminent fashion journalist of her generation. Line Sheet offers incisive reportage on all aspects of the industry and its biggest players. Every Wednesday, Lauren is joined by the beauty industry’s leading reporter, Rachel Strugatz, who writes the definitive guide to what’s happening across the category, from M&A to executive shuffles.
|
|
|
Need help? Review our FAQ page or contact us for assistance. For brand partnerships, email ads@puck.news.
You received this email because you signed up to receive emails from Puck, or as part of your Puck account associated with . To stop receiving this newsletter and/or manage all your email preferences, click
here.
|
|
Puck is published by Heat Media LLC. 107 Greenwich St, New York, NY 10006
|
|
|
|